The idea that the government could forcibly seize ownership of a groundbreaking invention you created is chilling. But that is the prospect the Biden administration seeks to invoke against American innovators in the pharmaceutical space — the driving force behind two-thirds of global drug discoveries.  

President Joe Biden’s misguided proposal not only jeopardizes the incentive to innovate but could also lead to a mass exodus of talent and research initiatives from the United States.